Ironsides Asset Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Sell
208
-25
-11% -$25.5K 0.06% 72
2026
Q1
$214K Hold
233
0.05% 76
2025
Q4
$250K Buy
+233
New +$223K 0.06% 65

Other funds holding LLY

Ironsides Asset Advisors's LLY Position: Q2 2026 in Review

Ironsides Asset Advisors reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $25.5K and leaving 208 shares worth $249K. The position accounts for 0.06% of the portfolio, ranked #72.

Ironsides Asset Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $250K in Q4 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ironsides Asset Advisors held 208 shares of Eli Lilly worth $249K as of Q2 2026.
  • Ironsides Asset Advisors sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.06% of Ironsides Asset Advisors's portfolio in Q2 2026, its #72 holding.
  • Ironsides Asset Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Ironsides Asset Advisors's Eli Lilly position peaked at $250K in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ironsides Asset Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.